Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
29.55
+0.07 (0.22%)
Feb 11, 2026, 2:14 PM EST - Market open
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $526.83 million as of February 11, 2026. Its market cap has increased by 444.27% in one year.
Market Cap
526.83M
Enterprise Value
427.26M
1-Year Change
444.27%
Ranking
Category
Stock Price
$29.55
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $526.83M, an increase of 190.37%. That is a compound annual growth rate of 20.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 531.56M | 9.31% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 559.48M |
| Solid Biosciences | 539.92M |
| Gossamer Bio | 539.29M |
| Ginkgo Bioworks Holdings | 524.60M |
| Keros Therapeutics | 522.49M |
| Tenax Therapeutics | 518.89M |
| Alto Neuroscience | 517.25M |
| Lexeo Therapeutics | 513.83M |